Pharmacoepidemiology and Drug Safety

Papers
(The H4-Index of Pharmacoepidemiology and Drug Safety is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
113
Issue Information73
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer54
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research53
External validity in distributed data networks44
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”39
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–201837
Issue Information37
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review36
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries34
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data34
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review33
ORAL PRESENTATION28
Data Resource Profile: The Danish National Hospital Medicine Register28
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems26
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries25
Causal Forests Versus Inverse Probability of Treatment Weighting to Adjust for Cluster‐Level Confounding: A Parametric and Plasmode Simulation Study Based on US 24
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study24
Issue Information23
Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis23
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+22
Letter to the Editor22
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark22
0.34191417694092